ALOY Q1 2024 Earnings EPS Misses Estimates Significantly Stock Rises Unexpectedly ABBV Q1 2026 Earnings Modest EPS Beat Amidst Market Stability Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher EXLS Q1 2026 Earnings Adjusted EPS Beats Estimates as Operational Efficiency Gains Traction BILL Q1 2026 Earnings EPS Beat Drives Modest Stock Decline Amid Revenue Data Gap